等待开盘 08-21 09:30:00 美东时间
-0.070
-3.33%
今日重点评级关注:HC Wainwright & Co.:维持Precigen"买入"评级,目标价从14美元升至18美元;HC Wainwright & Co.:维持Sophia Genetics"买入"评级,目标价从12美元升至14美元
08-06 11:36
8x8 shares are trading lower after the company reported Q1 financial results and issued Q2 adjusted EPS guidance below estimates.
08-05 20:50
U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Wednesday. Shares of Space Exploration Technologies Corp (NASDAQ:SPCX) fell sharply in pre-market trading after the company reported its first quarterly financial results as a public company. SpaceX reporte...
08-05 20:03
8x8 (NASDAQ:EGHT) affirms FY2027 Adj EPS guidance from $0.33-$0.38 to $0.33-$0.38 vs $0.36 analyst estimate. Raises FY2027 sales outlook from $727.000 million-$747.000 million to $745.000 million-$765.000 million vs $738.012 million estimate.
08-05 04:47
8x8 (NASDAQ:EGHT) is looking for Q2 Adj EPS of $0.07-$0.08 vs $0.09 analyst estimate. sees sales of $185.000 million-$190.000 million vs $184.322 million analyst estimate.
08-05 04:46
今日重点评级关注:Oppenheimer:维持Protara Therapeutics"跑赢大市"评级,目标价从25美元升至28美元;Piper Sandler:维持Bright Minds Biosciences"超配"评级,目标价从190美元升至220美元
05-21 12:05
Rosenblatt analyst Catharine Trebnick maintains 8x8 (NASDAQ:EGHT) with a Buy and raises the price target from $2.75 to $3.
05-20 20:20
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据8x8业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** - 总营收1.852亿美元,实现连续第四个季度同比增长 - 服务营收1.802亿美元,同比增长4.65% - 基于使用量的营收同比增长超过70%,占服务营收比例从去年同期的14%增至23% **盈利能力:** - 毛利润1.189亿美元,较指导区间中点高出约200万美元 - 毛利率64.2%,因产品组合向低毛利率的使用量产品转移而环比略有下降 - 营业利润1,980万美元,营业利润率10.7%,超出指导区间上限 - 净利润1,660万美元,完全摊薄每股收益0.1
05-20 12:08
Rubico Incorporation涨-21.90%;Auddia Inc.涨-6.88%;Creative Global Technology Holdings Limited Class A涨-6.63%
05-20 08:05
Gainers 8x8 (NASDAQ:EGHT) shares increased by 14.5% to $2.76 during Tuesday's ...
05-20 05:05